In this episode of the Psychedelic Spotlight podcast, we spend some time with Timothy Ko who is the CEO of Entheon Biomedical (CSE: ENBI) (OTCQB: ENTBF) (FSE: “1XU1”), a biotechnology company focused on developing psychedelic medicines to treat addiction. In our conversation with Mr. Ko, we discuss how the company plans to utilize the psychedelic […]
In this episode of the Psychedelic Spotlight podcast, we speak with David Champion who is the Co-Founder and CEO of Maya Health, a company dedicated to empowering psychedelic practitioners with the technology and insight they need to scale psychedelic healthcare safely and effectively. In our conversation with David, we learn how Maya Health is leveraging […]
HAVN Life Sciences Inc. CEO, Tim Moore, updates the recent launch of its new line of natural health products and more. *To learn more about the company featured in this video and the work they’re doing, visit their website: https://havnlife.com and https://yourhavnlife.com *Get the latest industry news around all things psychedelics by visiting our website, […]
In this Psychedelic Spotlight exclusive, we speak with California Senator, Scott Wiener (D-San Francisco), to discuss Senate Bill 519 (SB-519) which aims to decriminalize the possession and sharing of certain psychedelics within the state of California, and, on the heels of the bill receiving approval from the State Senate earlier this month. In our conversation […]
In this episode of the Psychedelic Spotlight podcast, we feature Anthony Tennyson, CEO of Awakn Life Sciences, a biotechnology company with clinical operations developing and delivering psychedelic medicine to treat addiction. In our conversation with Anthony, we gain insight on Awakn’s psychedelic therapy delivery activities, the company’s plans to expand across the EU, and what […]
In this episode of the Psychedelic Spotlight podcast, we catch up with Daniel Carcillo, Founder, and CEO of Wesana Health, to talk about the company’s recent listing on the #CSE, their plans to uplist to the NASDAQ, and their recently formed partnership with the University of South Carolina and what it means for the development […]
In this episode of the Psychedelic Spotlight podcast, we feature James Hallifax, Co-Founder of The Psychedelic Investor, an emerging media company covering the medicinal psychedelics space and partner of Psychedelic Spotlight. In our conversation with James, we talked about what led him to launching The Psychedelic Investor, the potential he sees in the medicinal psychedelics […]
August 4, 2021- This week’s Psychedelic Business News top stories include: – Virtual reality startup, Tripp Inc., raises $11 million – Research from Numinus involving psychedelics for PTSD makes significant strides – We catch up with MindMed and Mindcure on their recent headlines – Psychable discusses how they are connecting individuals to psychedelic healthcare practitioners […]
July 21, 2021- This week’s Psychedelic Business News top stories include: – Wesana Health & The University of Southern Carolina Team up To Develop More Effective Treatments for TBI – The World’s Largest Psychedelic Trial To Date Achieves Major Milestone – Awkn Life Sciences Welcomes a World-Renowned Neuroscientist to it’s Team – Psychedelic Passage On […]
July 7, 2021- This week’s Psychedelic Business News top stories include: – Mydecine Innovations Group Makes A Huge Mushroom Discovery – Field Trip Health Prepares for the Nasdaq – Psychedelic Research Makes It’s Way To Texas – We Introduce You To The First-Ever Female-Founded Psychedelic Biotech Company, Aphrodite AND MORE! Read The Latest News: https://bit.ly/2TGUyrM […]
